In addition to its use for imaging gastric cancer cell lines (MGC-803), CDs modified with ribonuclease A (RNase A@CDs) showed potency as anti-cancer candidates due to the concentration-dependent cytotoxic effect shown by RNase A@CDs. The gene discussed is RNASE1; the disease is gastric cancer.